Moneycontrol PRO
HomeNewsTarsonsproducts
Jump to
  • Buy Marksans Pharma; target of Rs 80: Arihant Capital

    Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 80 in its research report dated August 19, 2022.

  • Buy Marksans Pharma; target of Rs 80: Arihant Capital

    Buy Marksans Pharma; target of Rs 80: Arihant Capital

    Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 80 in its research report dated June 06, 2022.

  • Buy Marksans Pharma; target of Rs 86: Arihant Capital

    Buy Marksans Pharma; target of Rs 86: Arihant Capital

    Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 86 in its research report dated February 16, 2022.

  • Accumulate Marksans Pharma; target of Rs 86: Arihant Capital

    Accumulate Marksans Pharma; target of Rs 86: Arihant Capital

    Arihant Capital recommended Accumulate rating on Marksans Pharma with a target price of Rs 86 in its research report dated Jun 01, 2021.

  • Hold Marksans Pharma; target of Rs 31: Centrum

    Hold Marksans Pharma; target of Rs 31: Centrum

    Centrum recommended hold rating on Marksans Pharma with a target price of Rs 31 in its research report dated June 11, 2018.

  • Hold Marksans Pharma; target of Rs 31: Centrum Research

    Hold Marksans Pharma; target of Rs 31: Centrum Research

    Centrum Research recommended hold rating on Marksans Pharma with a target price of Rs 31 in its research report dated June 11, 2018.

  • Buy Marksans Pharma; target of Rs 55: Centrum

    Buy Marksans Pharma; target of Rs 55: Centrum

    Centrum is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 55 in its research report dated February 20, 2018.

  • Hold Marksans Pharma; target of Rs 45: Centrum

    Hold Marksans Pharma; target of Rs 45: Centrum

    Centrum recommended hold rating on Marksans Pharma with a target price of Rs 45 in its research report dated November 20, 2017.

  • Hold Marksans Pharma; target of Rs 41: Centrum

    Hold Marksans Pharma; target of Rs 41: Centrum

    Centrum recommended hold rating on Marksans Pharma with a target price of Rs 41 in its research report dated February 07, 2017.

  • Hold Marksans Pharma; target of Rs 36: Centrum

    Hold Marksans Pharma; target of Rs 36: Centrum

    Centrum recommended hold rating on Marksans Pharma with a target price of Rs 36 in its research report dated November 17, 2016.

  • Buy Marksans Pharma; target of Rs 60: Centrum

    Buy Marksans Pharma; target of Rs 60: Centrum

    Centrum is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 60 in its research report dated September 29, 2016.

  • Buy Marksans Pharma; target of Rs 70: Dynamic Levels

    Buy Marksans Pharma; target of Rs 70: Dynamic Levels

    Dynamic Levels is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 70 in its research report dated September 30, 2016.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347